-transparent.png){kind=logo}
The prognostic value of oestrogen receptor analysis is demonstrated in 150 patients with infiltrating breast carcinoma. Recurrence of tumour was earlier and more frequent in the receptor negative than in the receptor positive cases. There was more early deaths in the receptor negative group. The mean follow-up time was 30 months.
Related Publications
F Hartveit, and
H Maartmann-Moe, and
K F Støa, and
M Tangen, and
T Thorsen
March 1990,
Journal of clinical pathology,
F Hartveit, and
H Maartmann-Moe, and
K F Støa, and
M Tangen, and
T Thorsen
December 1990,
The Journal of pathology,
F Hartveit, and
H Maartmann-Moe, and
K F Støa, and
M Tangen, and
T Thorsen
April 1988,
British journal of cancer,
F Hartveit, and
H Maartmann-Moe, and
K F Støa, and
M Tangen, and
T Thorsen
October 2000,
The Journal of pathology,
F Hartveit, and
H Maartmann-Moe, and
K F Støa, and
M Tangen, and
T Thorsen
October 1998,
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology,
F Hartveit, and
H Maartmann-Moe, and
K F Støa, and
M Tangen, and
T Thorsen
January 1987,
Breast cancer research and treatment,
F Hartveit, and
H Maartmann-Moe, and
K F Støa, and
M Tangen, and
T Thorsen
January 1980,
Lancet (London, England),
F Hartveit, and
H Maartmann-Moe, and
K F Støa, and
M Tangen, and
T Thorsen
September 2006,
British journal of cancer,
F Hartveit, and
H Maartmann-Moe, and
K F Støa, and
M Tangen, and
T Thorsen
February 1990,
British journal of cancer,
F Hartveit, and
H Maartmann-Moe, and
K F Støa, and
M Tangen, and
T Thorsen
January 2008,
Lancet (London, England),
